# Gαi2 Induces Cell Migration in PC3 Prostate Cancer Cells in the Absence of Rac1 Activation

**Authors:** Rarnice Johnson, Silvia Caggia, Shafiq A. Khan

PMC · DOI: 10.3390/ijms26062663 · International Journal of Molecular Sciences · 2025-03-15

## TL;DR

This study shows that Gαi2 promotes prostate cancer cell migration without needing Rac1 activation, suggesting a new pathway for cancer spread.

## Contribution

The paper reveals that Gαi2 induces cell migration independently of Rac1 activation in prostate cancer cells.

## Key findings

- Gαi2 overexpression increases cell migration in PC3 cells regardless of Rac1 activity.
- Gαi2 inhibition blocks migration caused by active Gαi2, but not Rac1 inhibition.
- Rac1-dependent Wave2 activation is impaired when Gαi2 is knocked down.

## Abstract

Metastatic prostate cancer occurs when the tumor spreads from the prostate gland to other parts of the body. Previous studies have shown that Gαi2, a subunit of the heterotrimeric G protein complex, plays a critical role in inducing cell migration and invasion in prostate cancer cells in response to diverse stimuli. Rac1 is a small rho-GTPase, which is activated by the phosphoinositide 3-kinase (PI3K)/AKT pathway and plays an essential role during cell migration. Previous studies have shown that the knockdown of Gαi2 attenuates cell migration without causing any reduction in basal Rac1 activity in both PC3 and DU145 cells, and has only marginal effects on the epidermal growth facotor (EGF)-induced increase in Rac1 activity. Therefore, Gαi2 may be involved in the regulation of cell motility and invasion independently or downstream of Rac1 activation. In this study, we investigated the possible mechanism of Gαi2 at the level of the Rac1-dependent activation of Wiskott-Aldrich Syndrome Protein)-family verprolin homologous protein2 (Wave2) and actin related protein 2/3 (Arp 2/3) proteins, downstream effectors of activated Rac1. PC3 cells with a stable overexpression of constitutively active Rac1 were transfected with control siRNA or Gαi2 siRNA to knockdown endogenous Gαi2 expression. Western blot analysis showed that the Rac1-dependent activation of Wave2 was impaired in the absence of Gαi2. The overexpression of constitutively active Gαi2 (Gαi2-Q205L) in PC3 cells significantly increased cell migration compared to cells transfected with control plasmids. In the parallel experiments, a specific Gαi2 inhibitor blocked Giα2-Q205L-induced cell migration in PC3 cells. Furthermore, the Rac1 inhibitor did not block increased cell migration in PC3 cells overexpressing constitutively active Gαi2. We conclude that activated Gαi2 plays a crucial role in cell migration in prostate cancer cells independent of Rac1 activation.

## Linked entities

- **Genes:** GAI2 (DELLA protein GAI 2) [NCBI Gene 547719], RAC1 (Rac family small GTPase 1) [NCBI Gene 5879], WASF2 (WASP family member 2) [NCBI Gene 10163], ARP2_3 (Arp2/3 complex subunit, actin nucleation center) [NCBI Gene 19247154], EGF (epidermal growth factor) [NCBI Gene 1950]
- **Proteins:** GAI2 (DELLA protein GAI 2), RAC1 (Rac family small GTPase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), AKT1 (AKT serine/threonine kinase 1), WASF2 (WASP family member 2), ARP2_3 (Arp2/3 complex subunit, actin nucleation center), EGF (epidermal growth factor)
- **Diseases:** prostate cancer (MONDO:0005159)

## Full-text entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, WASF2 (WASP family member 2) [NCBI Gene 10163] {aka IMD2, SCAR2, WASF4, WAVE2, dJ393P12.2}, WAS (WASP actin nucleation promoting factor) [NCBI Gene 7454] {aka IMD2, SCNX, THC, THC1, WASP, WASPA}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, RAC1 (Rac family small GTPase 1) [NCBI Gene 5879] {aka MIG5, MRD48, Rac-1, TC-25, p21-Rac1}
- **Diseases:** Metastatic prostate cancer (MESH:D011471), tumor (MESH:D009369)
- **Mutations:** Q205L
- **Cell lines:** PC3 Prostate Cancer — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_M124), PC3 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0035), DU145 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0105)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11941931/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11941931/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC11941931/full.md

---
Source: https://tomesphere.com/paper/PMC11941931